Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
Naynesh Kamani(American Association of Blood Banks), Shalini Shenoy(Washington University in St. Louis), Michael A. Pulsipher(Primary Children's Hospital), Joel A. Brochstein(Cohen Children's Medical Center), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Michael Grimley(Cincinnati Children's Hospital Medical Center), Mark C. Walters(UCSF Benioff Children's Hospital), Mary Eapen(Medical College of Wisconsin), John E. Levine(Icahn School of Medicine at Mount Sinai), Julie A. Panepinto(National Institutes of Health), Shelly Carter(European Society for Blood and Marrow Transplantation), Theodore B. Moore(University of California, Los Angeles), Kirk R. Schultz(University of British Columbia), Stephen R. Spellman(National Marrow Donor Program), Sonali Chaudhury(Northwestern University), Victor Aquino(The University of Texas Southwestern Medical Center), Suhag Parikh(Emory University), Jane Sande(Children's National), Brian M. Freed(University of Colorado Denver)
Cited by 201
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Sickle cell disease
|Nature Reviews Disease Primers|2018|1.4k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577